Deutsche Bank’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-94,394
| Closed | -$43.4K | – | 3681 |
|
|
2025
Q1 | $43.4K | Sell |
94,394
-221,265
| -70% | -$140K | ﹤0.01% | 3400 |
|
|
2024
Q4 | $234K | Buy |
315,659
+249,616
| +378% | +$301K | ﹤0.01% | 3029 |
|
|
2024
Q3 | $104K | Buy |
66,043
+34,153
| +107% | +$60.8K | ﹤0.01% | 3208 |
|
|
2024
Q2 | $53.6K | Sell |
31,890
-6,847
| -18% | -$12.3K | ﹤0.01% | 3314 |
|
|
2024
Q1 | $93K | Sell |
38,737
-1,552
| -4% | -$3.33K | ﹤0.01% | 3199 |
|
|
2023
Q4 | $61.6K | Hold |
40,289
| – | – | ﹤0.01% | 3392 |
|
|
2023
Q3 | $43.9K | Hold |
40,289
| – | – | ﹤0.01% | 3432 |
|
|
2023
Q2 | $92.3K | Sell |
40,289
-12,336
| -23% | -$32.7K | ﹤0.01% | 3305 |
|
|
2023
Q1 | $128K | Buy |
52,625
+15,979
| +44% | +$36.6K | ﹤0.01% | 3212 |
|
|
2022
Q4 | $70K | Buy |
36,646
+556
| +2% | +$1.18K | ﹤0.01% | 3475 |
|
|
2022
Q3 | $87K | Buy |
36,090
+2,998
| +9% | +$8.3K | ﹤0.01% | 3393 |
|
|
2022
Q2 | $61K | Sell |
33,092
-4,803
| -13% | -$9.16K | ﹤0.01% | 3700 |
|
|
2022
Q1 | $80K | Sell |
37,895
-4,516
| -11% | -$12.5K | ﹤0.01% | 3660 |
|
|
2021
Q4 | $167K | Buy |
42,411
+2,158
| +5% | +$10.5K | ﹤0.01% | 3465 |
|
|
2021
Q3 | $194K | Sell |
40,253
-126,028
| -76% | -$517K | ﹤0.01% | 3581 |
|
|
2021
Q2 | $764K | Buy |
166,281
+78,283
| +89% | +$377K | ﹤0.01% | 2954 |
|
|
2021
Q1 | $517K | Sell |
87,998
-65,178
| -43% | -$451K | ﹤0.01% | 3077 |
|
|
2020
Q4 | $524K | Sell |
153,176
-466,154
| -75% | -$889K | ﹤0.01% | 2876 |
|
|
2020
Q3 | $892K | Buy |
619,330
+599,118
| +2,964% | +$1.07M | ﹤0.01% | 2271 |
|
|
2020
Q2 | $40K | Buy |
20,212
+6,079
| +43% | +$11.9K | ﹤0.01% | 3909 |
|
|
2020
Q1 | $27K | Sell |
14,133
-87,323
| -86% | -$260K | ﹤0.01% | 3817 |
|
|
2019
Q4 | $420K | Sell |
101,456
-25,697
| -20% | -$98.9K | ﹤0.01% | 2813 |
|
|
2019
Q3 | $381K | Sell |
127,153
-152,042
| -54% | -$471K | ﹤0.01% | 2815 |
|
|
2019
Q2 | $1.75M | Buy |
279,195
+19,028
| +7% | +$114K | ﹤0.01% | 2479 |
|
|
2019
Q1 | $1.44M | Sell |
260,167
-35,452
| -12% | -$215K | ﹤0.01% | 2736 |
|
|
2018
Q4 | $1.96M | Sell |
295,619
-10,923
| -4% | -$88.5K | ﹤0.01% | 2412 |
|
|
2018
Q3 | $3.27M | Sell |
306,542
-25,146
| -8% | -$288K | ﹤0.01% | 2514 |
|
|
2018
Q2 | $3.98M | Sell |
331,688
-95,480
| -22% | -$977K | ﹤0.01% | 2475 |
|
|
2018
Q1 | $3.66M | Sell |
427,168
-120,951
| -22% | -$1.12M | ﹤0.01% | 2462 |
|
|
2017
Q4 | $5.41M | Buy |
548,119
+217,214
| +66% | +$2.26M | ﹤0.01% | 1971 |
|
|
2017
Q3 | $4.06M | Buy |
330,905
+13,259
| +4% | +$196K | ﹤0.01% | 2046 |
|
|
2017
Q2 | $5.22M | Buy |
317,646
+182,554
| +135% | +$2.83M | ﹤0.01% | 1888 |
|
|
2017
Q1 | $1.94M | Buy |
135,092
+108,516
| +408% | +$1.61M | ﹤0.01% | 2267 |
|
|
2016
Q4 | $367K | Sell |
26,576
-30,597
| -54% | -$491K | ﹤0.01% | 3358 |
|
|
2016
Q3 | $1.03M | Buy |
57,173
+15,147
| +36% | +$244K | ﹤0.01% | 2811 |
|
|
2016
Q2 | $601K | Buy |
42,026
+2,054
| +5% | +$27.9K | ﹤0.01% | 3176 |
|
|
2016
Q1 | $477K | Buy |
39,972
+24,005
| +150% | +$252K | ﹤0.01% | 3248 |
|
|
2015
Q4 | $211K | Sell |
15,967
-204,145
| -93% | -$2.51M | ﹤0.01% | 3698 |
|
|
2015
Q3 | $2.36M | Buy |
220,112
+192,766
| +705% | +$2.11M | ﹤0.01% | 2379 |
|
|
2015
Q2 | $219K | Sell |
27,346
-56,863
| -68% | -$418K | ﹤0.01% | 3844 |
|
|
2015
Q1 | $554K | Buy |
84,209
+52,378
| +165% | +$358K | ﹤0.01% | 3244 |
|
|
2014
Q4 | $202K | Buy |
31,831
+29,750
| +1,430% | +$240K | ﹤0.01% | 4296 |
|
|
2014
Q3 | $20K | Sell |
2,081
-35,580
| -94% | -$380K | ﹤0.01% | 5199 |
|
|
2014
Q2 | $423K | Sell |
37,661
-7,698
| -17% | -$82.7K | ﹤0.01% | 3592 |
|
|
2014
Q1 | $548K | Sell |
45,359
-2,236
| -5% | -$28.6K | ﹤0.01% | 3275 |
|
|
2013
Q4 | $599K | Sell |
47,595
-77,221
| -62% | -$1.23M | ﹤0.01% | 2975 |
|
|
2013
Q3 | $2.08M | Buy |
124,816
+12,486
| +11% | +$209K | ﹤0.01% | 2467 |
|
|
2013
Q2 | $1.7M | Buy |
+112,330
| New | +$1.71M | ﹤0.01% | 2333 |
|
Other funds holding LXRX
AG
SL
SSA
SC
GCP
